Aflofarm Farmacja Polska sp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-05-23
Share capital
26,271,500.00 PLN
Activity description

Aflofarm Farmacja Polska is a Polish pharmaceutical company that has operated in healthcare for 30 years and has led Poland’s over-the-counter market since 2012, with brands such as Desmoxan, Neosine and Dafurag. Its portfolio includes more than 180 brands, including prescription and OTC medicines, medical devices, cosmetics and dietary supplements; the company employs over 1,500 people and exports products to 31 countries.

Registered address
Partyzancka 133/151, 95-200 Pabianice, Poland
Email
Phone
Social media
Electronic delivery address
AE:PL-19940-99753-RSTSA-28

Financials

Revenue history (in m)

From the notes

Current income tax (CIT due)$13,469,923

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 89 days late). All were audited by a statutory auditor.

  • 202508/07/2026
  • 202410/07/2025
  • 202310/07/2024
  • 202204/07/2023
  • 202112/10/2022
  • 202013/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Sector · Manufacturing232 / 24,548
Top <1%
City · Pabianice1 / 367
Top <1%
Voivodeship · Łódzkie23 / 15,323
Top <1%
Country · Poland714 / 297,069
Top <1%

Results vs industry

Revenue
This companyUSD 302.02mMedianUSD 913.43kAverageUSD 25.82m
Net profit
This companyUSD 59.44mMedianUSD 14.22kAverageUSD 2.77m
Operating costs
This companyUSD 223.23mMedianUSD 846.99kAverageUSD 21.42m
Assets
This companyUSD 405.91mMedianUSD 897.46kAverageUSD 31.52m

Websites

The site is available in: English and Russian.

Public procurement

The company is the contractor in one public sector contract, worth USD 430.82.

SubjectAmount
Purchase and delivery of medicines
$430.82

Trademarks

The company holds 472 active trademarks registered with the Polish Patent Office. 34 applications are pending. 326 marks have expired or were not registered. The first mark was filed in 1988.

MarkNumberClassesStatusProtected until
osegrypin (word)Z.5993785Protected Mar 12, 2036
osemivir (word)Z.5993765Protected Mar 12, 2036
ibusimplic (word)Z.5981295Protected Feb 16, 2036
more (word)Z.5974353, 5Protected Jan 30, 2036
ASECURIN (word)Z.5947215Protected Dec 2, 2035
MarkProtected until
osegrypin (word)Mar 12, 2036
osemivir (word)Mar 12, 2036
ibusimplic (word)Feb 16, 2036
more (word)Jan 30, 2036
ASECURIN (word)Dec 2, 2035

Job offers

The company has its own careers page: aflofarm.com.pl/pl/kariera.

Authorized Representatives

Bogumiła Jadwiga Ciszewska age 58 – Management Board Member
Jacek Furman age 51 – President of the Management Board
Wojciech Maciej Furman age 47 – Management Board Member
Tomasz Szymon Furman age 42 – Management Board Member
Hanna Wahl age 61 – Management Board Member

Manner of representation

For making declarations of will on behalf of the company with respect to both property and non-property rights and obligations, and for signing on its behalf, two members of the management board or a member of the management board jointly with a commercial proxy are authorized.

Supervisory board

Andrzej Zbigniew Furman age 75 – Supervisory Board Member
Grażyna Furman age 75 – Supervisory Board Member
Tomasz Jasiński age 45 – Supervisory Board Member

Ownership

OwnerSharesShare valueStake
138,719$2,341,960.4333.0013%
126,097$2,128,866.1529.9985%
126,097$2,128,866.1529.9985%
Others
29,431$496,876.697.0017%

Andrzej Zbigniew Furman, Jacek Furman and Wojciech Maciej Furman hold a combined 93% – the ownership structure indicates family control.

Beneficial owners

Person

Subsidiaries

NameStake
Trec Nutrition sp. z o.o.
100%

Bank accounts

Registered as a VAT taxpayer on 2003-11-01.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$1.1M
Buildings and premises
$21.2M

Public aid

17 public aid cases recorded, with a total value of $11,836,574.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$0
De minimis aid (in accordance with Commission Regulation 2023/2831)
$0
Regional investment aid
$1.4M

European Funds

ProjectEU co-financing
Expansion of Aflofarm's research and development facilities to increase R&D activity in the development of new medicinal products, medical devices and cosmetics
$725.7K

Regulatory authorisations

AuthorityTypeStatus
Waste generation Active

Competitors

Name
Adamed Pharma S.A.
Bausch Health Poland sp. z o.o.
USP Zdrowie sp. z o.o.
Biofarm sp. z o.o.
Zentiva Polska sp. z o.o.
Angelini Pharma Polska sp. z o.o.
Farmak International sp. z o.o.
Synoptis Pharma sp. z o.o.
Polfarmex S.A.
SUN-Farm sp. z o.o.

Change history

DateEvent
2012-10-25Share capital increase
2002-01-22Share capital increase
2001-09-06Name change
2001-05-23Entered in the register

FAQ

Last updated: 2026-07-15